Article ; Online: Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis.
2023 Volume 180, Page(s) 106115
Abstract: ... of the virus in causing infectious mononucleosis (IM) affecting B-cells and epithelial cells and ...
Abstract | Background: Epstein-Barr virus (EBV) affects more than 90% of global population. The role of the virus in causing infectious mononucleosis (IM) affecting B-cells and epithelial cells and in the development of EBV associated cancers is well documented. Investigating the associated interactions can pave way for the discovery of novel therapeutic targets for EBV associated lymphoproliferative (Burkitt's Lymphoma and Hodgkin's Lymphoma) and non-lymphoproliferative diseases (Gastric cancer and Nasopharyngeal cancer). Methods: Based on the DisGeNET (v7.0) data set, we constructed a disease-gene network to identify genes that are involved in various carcinomas, viz. Gastric cancer (GC), Nasopharyngeal cancer (NPC), Hodgkin's lymphoma (HL) and Burkitt's lymphoma (BL). We identified communities in the disease-gene network and performed functional enrichment using over-representation analysis to detect significant biological processes/pathways and the interactions between them. Result: We identified the modular communities to explore the relation of this common causative pathogen (EBV) with different carcinomas such as GC, NPC, HL and BL. Through network analysis we identified the top 10 genes linked with EBV associated carcinomas as CASP10, BRAF, NFKBIA, IFNA2, GSTP1, CSF3, GATA3, UBR5, AXIN2 and POLE. Further, the tyrosine-protein kinase (ABL1) gene was significantly over-represented in 3 out of 9 critical biological processes, viz. in regulatory pathways in cancer, the TP53 network and the Imatinib and chronic myeloid leukemia biological processes. Consequently, the EBV pathogen appears to target critical pathways involved in cellular growth arrest/apoptosis. We make our case for BCR-ABL1 tyrosine-kinase inhibitors (TKI) for further clinical investigations in the inhibition of BCR-mediated EBV activation in carcinomas for better prognostic and therapeutic outcomes. |
---|---|
MeSH term(s) | Humans ; Herpesvirus 4, Human/genetics ; Burkitt Lymphoma/genetics ; Burkitt Lymphoma/complications ; Epstein-Barr Virus Infections/genetics ; Epstein-Barr Virus Infections/complications ; Hodgkin Disease/complications ; Stomach Neoplasms/complications ; Nasopharyngeal Neoplasms/genetics ; Nasopharyngeal Neoplasms/complications ; Protein-Tyrosine Kinases ; Carcinoma ; Carcinogenesis/genetics ; Tyrosine |
Chemical Substances | Protein-Tyrosine Kinases (EC 2.7.10.1) ; Tyrosine (42HK56048U) |
Language | English |
Publishing date | 2023-05-01 |
Publishing country | England |
Document type | Journal Article |
ZDB-ID | 632772-2 |
ISSN | 1096-1208 ; 0882-4010 |
ISSN (online) | 1096-1208 |
ISSN | 0882-4010 |
DOI | 10.1016/j.micpath.2023.106115 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 2136: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.